Plasma phospholipid arachidonic acid and lignoceric acid are associated with the risk of cardioembolic stroke

Nutrition Research

Volumn 35, Issue 11, 2015, Pages 1001-1008

  Chung, Hye Kyung ^a   Cho, Yoonsu ^b   Do, Hyun Ju ^b   Oh, Kyungmi ^c   Seo, Woo Keun ^c   Shin, Min Jeong ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Arachidonic acid; Cardioembolic stroke; Fatty acid; Lignoceric acid; Trans fat

Indexed keywords

ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSADIENOIC ACID; DOCOSAHEXAENOIC ACID; EICOSADIENOIC ACID; ELAIDIC ACID; ERUCIC ACID; FATTY ACID; GAMMA LINOLENIC ACID; GONDOIC ACID; ICOSAPENTAENOIC ACID; ICOSATRIENOIC ACID; LAURIC ACID; LIGNOCERIC ACID; LINOLELAIDIC ACID; LINOLENIC ACID; MYRISTIC ACID; MYRISTOLEIC ACID; NERVONIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; PHOSPHOLIPID; STEARIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOEMBOLIC STROKE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE REGISTRY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; KOREAN (PEOPLE); MALE; MIDDLE AGED; PATIENT SELECTION; PHOSPHOLIPID BLOOD LEVEL; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL ASPECT; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; BLOOD; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; SOUTH KOREA;

AGED; AGED, 80 AND OVER; ARACHIDONIC ACID; BRAIN ISCHEMIA; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; STROKE;

EID: 84952639713     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.09.007     Document Type: Article

References (48)

1. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
2. Lackland D.T., Roccella E.J., Deutsch A.F., Fornage M., George M.G., Howard G., et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 2014, 45:315-353.
3. Palacio S., Hart R.G. Neurologic manifestations of cardiogenic embolism: an update. Neurol Clin 2002, 20:179-193.
4. Eriksson S.E., Olsson J.E. Survival and recurrent strokes in patients with different subtypes of stroke: a fourteen-year follow-up study. Cerebrovasc Dis 2001, 12:171-180.
5. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the anticoagulation and factors in atrial fibrillation (ATRIA) study. JAMA 2001, 285:2370-2375.
6. Korean Stroke Registry Study Group Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke). Circ Cardiovasc Qual Outcomes 2012, 5:327-334.
7. Hong K.S., Bang O.Y., Kang D.W., Yu K.H., Bae H.J., Lee J.S., et al. Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the Korean stroke society and clinical research center for stroke. J Stroke 2013, 15(1):2-20.
8. Nakayama T., Yokoyama T., Yoshiike N., Zaman M.M., Date C., Tanaka H., et al. Population attributable fraction of stroke incidence in middle-aged and elderly people: contributions of hypertension, smoking and atrial fibrillation. Neuroepidemiology 2000, 19:217-226.
9. Riboli E., Ronnholm H., Saracci R. Biological markers of diet. Cancer Surv 1987, 6:685-718.
10. Simon J.A., Fong J., Bernert J.T., Browner W.S. Serum fatty acids and the risk of stroke. Stroke 1995, 26:778-782.
11. Iso H., Sato S., Umemura U., Kudo M., Koike K., Kitamura A., et al. Linoleic acid, other fatty acids, and the risk of stroke. Stroke 2002, 33:2086-2093.
12. Yaemsiri S., Sen S., Tinker L.F., Robinson W.R., Evans R.W., Rosamond W., et al. Serum fatty acids and incidence of ischemic stroke among postmenopausal women. Stroke 2013, 44:2710-2717.
13. Khawaja O., Bartz T.M., Ix J.H., Heckbert S.R., Kizer J.R., Zieman S.J., et al. Plasma free fatty acids and risk of atrial fibrillation (from the Cardiovascular Health Study). Am J Cardiol 2012, 110:212-216.
14. Fretts A.M., Mozaffarian D., Siscovick D.S., Djousse L., Heckbert S.R., King I.B., et al. Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study. J Am Heart Assoc 2014, 3.
15. Lin Y.K., Chen Y.C., Kao Y.H., Tsai C.F., Yeh Y.H., Huang J.L., et al. A monounsaturated fatty acid (oleic acid) modulates electrical activity in atrial myocytes with calcium and sodium dysregulation. Int J Cardiol 2014, 176(1):191-198.
16. Wilbring M., Ploetze K., Bormann S., Waldow T., Matschke K. Omega-3 polyunsaturated fatty acids reduce the incidence of postoperative atrial fibrillation in patients with history of prior myocardial infarction undergoing isolated coronary artery bypass grafting. Thorac Cardiovasc Surg 2014, 62:569-574.
17. Armaganijan L., Lopes R.D., Healey J.S., Piccini J.P., Nair G.M., Morillo C.A. Do omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials. Clinics (Sao Paulo) 2011, 66:1923-1928.
18. Seo W.K., Kim J., Kim Y.H., Kim J.H., Oh K., Koh S.B., et al. Elevated free fatty acid is associated with cardioembolic stroke subtype. Can J Neurol Sci 2011, 38:874-879.
19. Choi J.Y., Kim J.S., Kim J.H., Oh K., Koh S.B., Seo W.K. High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients. Neurology 2014, 82:1142-1148.
20. Kim Y.J., Kim O.Y., Cho Y., Chung J.H., Jung Y.S., Hwang G.S., et al. Plasma phospholipid fatty acid composition in ischemic stroke: importance of docosahexaenoic acid in the risk for intracranial atherosclerotic stenosis. Atherosclerosis 2012, 225(2):418-424.
21. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
22. Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986, 27:114-120.
23. Zendedel A., Habib P., Dang J., Lammerding L., Hoffmann S., Beyer C., et al. Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia. J Neuroimmunol 2015, 278:200-211.
24. Mozaffarian D., Aro A., Willett W.C. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009, 63(Suppl 2):S5-S21.
25. Chajès V., Biessy C., Ferrari P., Romieu I., Freisling H., Huybrechts I., et al. Plasma elaidic acid level as biomarker of industrial trans fatty acids and risk of weight change: report from the EPIC study. PLoS One 2015, 10(2).
26. Shao F., Ford D.A. Elaidic acid increases hepatic lipogenesis by mediating sterol regulatory element binding protein-1c activity in HuH-7 cells. Lipids 2014, 49(5):403-413.
27. Yaemsiri S., Sen S., Tinker L., Rosamond W., Wassertheil-Smoller S., He K. Trans fat, aspirin, and ischemic stroke in postmenopausal women. Ann Neurol 2012, 72(5):704-715.
28. Zapolska-Downar D., Kośmider A., Naruszewicz M. Trans fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol 2005, 56(4):611-625.
29. Aime-Sempe C., Folliguet T., Rucker-Martin C., Krajewska M., Krajewski S., Heimburger M., et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 1999, 34:1577-1586.
30. Harvey K.A., Walker C.L., Xu Z., Whitley P., Siddiqui R.A. Trans fatty acids: induction of a pro-inflammatory phenotype in endothelial cells. Lipids 2012, 47(7):647-657.
31. Park K.H., Kim J.M., Cho K.H. Elaidic acid (EA) generates dysfunctional high-density lipoproteins and consumption of EA exacerbates hyperlipidemia and fatty liver change in zebrafish. Mol Nutr Food Res 2014, 58(7):1537-1545.
32. Seeds M.C., Bass D.A. Regulation and metabolism of arachidonic acid. Clin Rev Allergy Immunol 1999, 17(1-2):5-26.
33. Li Y., Kang J.X., Leaf A. Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. Prostaglandins 1997, 54:511-530.
34. Ikeya Y., Fukuyama N., Mori H. Low plasma eicosapentaenoic acid concentration as a possible risk factor for intracerebral hemorrhage. Nutr Res 2015, 35(3):214-220.
35. Nozue T., Yamamoto S., Tohyama S., Fukui K., Umezawa S., Onishi Y., et al. Effects of serum n-3 to n-6 polyunSFAs ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease. Am J Cardiol 2013, 111(1):6-11.
36. Nishizaki Y., Shimada K., Tani S., Ogawa T., Ando J., Takahashi M., et al. Significance of imbalance in the ratio of serum n-3 to n-6 polyunSFAs in patients with acute coronary syndrome. Am J Cardiol 2014, 113(3):441-445.
37. Suda S., Katsumata T., Okubo S., Kanamaru T., Suzuki K., Watanabe Y., et al. Low serum n-3 polyunSFA/n-6 polyunSFA ratio predicts neurological deterioration in Japanese patients with acute ischemic stroke. Cerebrovasc Dis 2013, 36(5-6):388-393.
38. Hu F.B., Stampfer M.J., Manson J.E., Ascherio A., Colditz G.A., Speizer F.E., et al. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 1999, 70:1001-1008.
39. Matsumoto C., Hanson N.Q., Tsai M.Y., Glynn R.J., Gaziano J.M., Djousse L. Plasma phospholipid SFAs and heart failure risk in the Physicians' Health Study. Clin Nutr 2013, 32:819-823.
40. Grimsgaard S., Bonaa K.H., Jacobsen B.K., Bjerve K.S. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension 1999, 34:478-483.
41. United States Department of Agriculture, Agricultural Research Service USDA National Nutrient Database for Standard Reference: Release 27th Available from. http://www.ars.usda.gov/Services/docs.htm?docid=8964.
42. Kihara A. Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem 2012, 152:387-395.
43. Grosch S., Schiffmann S., Geisslinger G. Chain length-specific properties of ceramides. Prog Lipid Res 2012, 51:50-62.
44. Crowder C.M. Cell biology. Ceramides-friend or foe in hypoxia?. Science 2009, 324:343-344.
45. Wang X., Lin H., Gu Y. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis 2012, 11:25.
46. Kondo K., Ishida T., Yasuda T., Nakajima H., Mori K., Tanaka N., et al. Trans-fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll-like receptors. Mol Nutr Food Res 2015, 59(4):729-740.
47. Zhang R.L., Lu C.Z., Ren H.M., Xiao B.G. Metabolic changes of arachidonic acid after cerebral ischemia-reperfusion in diabetic rats. Exp Neurol 2003, 184(2):746-752.
48. Kaliannan K., Wang B., Li X.Y., Kim K.J., Kang J.X. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci Rep 2015, 5:11276.